Client news

A&O Shearman advises on the USD175 million follow-on equity offering by Mineralys Therapeutics Inc.

A&O Shearman advises on the USD175 million follow-on equity offering by Mineralys Therapeutics Inc.
A&O Shearman represented the underwriters in Mineralys Therapeutics, Inc.’s USD175m follow-on equity offering. Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone. 

The A&O Shearman team was led by U.S. capital markets partner Ilir Mujalovic with key support from associates Katya Bogdanov, Kaz Watanabe and Colin Cantwell. IP transactional partner JB Betker and associate Austin Grossfeld (associate, New York) provided advice on intellectual property matters. Financial services regulatory partner Jennifer Morton and associates Taylor Pugliese and Joshua Kim provided advice on financial services regulatory matters. Tax partner Lorenz Haselberger and associate Ryan Sedwick provided tax advice.

Related capabilities